Australia - English - Department of Health (Therapeutic Goods Administration)

novartis consumer health australasia pty ltd - diclofenac potassium -

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 25mg;  ;   - enteric coated tablet - 25 mg - active: diclofenac sodium 25mg     excipient: ammonia solution colloidal silicon dioxide hypromellose   silicone antifoam emulsion (enteric-coat)   pigment suspension white   pigment suspension white (colour-coat) lactose monohydrate macrogol 8000 magnesium stearate maize starch methacrylic acid copolymer microcrystalline cellulose polyethylene glycol hydrogenated castor oil   povidone purified talc     purified water     sodium starch glycolate - treatment of: inflammatory and degenerative forms of rheumatism - rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism; acute attacks of gout; post-traumatic and postoperative pain, inflammation, and swelling, e.g. following dental or orthopaedic surgery; painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis; as an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otitis. in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. fever alone is not an indication.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 50mg;  ;   - enteric coated tablet - 50 mg - active: diclofenac sodium 50mg     excipient: colloidal silicon dioxide hypromellose   silicon antifoam emulsion se2, enteric coat iron oxide red   iron oxide yellow   lactose monohydrate macrogol 8000 magnesium stearate maize starch methacrylic acid copolymer microcrystalline cellulose polyethylene glycol hydrogenated castor oil   povidone purified talc   sodium starch glycolate titanium dioxide   - treatment of: inflammatory and degenerative forms of rheumatism - rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism; acute attacks of gout; post-traumatic and postoperative pain, inflammation, and swelling, e.g. following dental or orthopaedic surgery; painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis; as an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otitis. in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. fever alone is not an indication.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 100mg;   - suppository - 100 mg - active: diclofenac sodium 100mg   excipient: hard fat - · treatment of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 12.5mg;   - suppository - 12.5 mg - active: diclofenac sodium 12.5mg   excipient: hard fat - · treatment of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 25mg;   - suppository - 25 mg - active: diclofenac sodium 25mg   excipient: hard fat - · treatment of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 50mg;   - suppository - 50 mg - active: diclofenac sodium 50mg   excipient: hard fat - · treatment of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac 46.5mg (as free acid = 50mg diclofenac sodium);   - dispersible tablet - 50 mg - active: diclofenac 46.5mg (as free acid = 50mg diclofenac sodium)   excipient: colloidal silicon dioxide croscarmellose sodium hydrogenated castor oil microcrystalline cellulose purified talc sodium starch glycolate - latest regulatory activity

New Zealand - English - Medsafe (Medicines Safety Authority)

haleon new zealand ulc - diclofenac diethylamine 1.16% equivalent to 1% diclofenac;  ;  ;  ;   - topical gel - 1 % - active: diclofenac diethylamine 1.16% equivalent to 1% diclofenac         excipient: caprylic/capric triglyceride carbomer cetomacrogol 1000 diethylamine isopropyl alcohol liquid paraffin creme 45 propylene glycol purified water - voltaren emulgel is indicated for the temporary relief of local pain and inflammation in acute soft tissue injuries and localised soft tissue rheumatism, and mild forms of osteoarthritis of the knees and fingers. (label claim)

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 100mg;  ;   - modified release tablet - 100 mg - active: diclofenac sodium 100mg     excipient: cetyl alcohol colloidal silicon dioxide hypromellose iron oxide red magnesium stearate opacode black s-1-17823 polysorbate 80 povidone purified talc sucrose titanium dioxide - · treatment of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism.